Open AccessTriplet Therapy Shows Promise Among Certain Ovarian Cancer Patients
Author(s) -
Catlin Nalley
Publication year - 2020
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000723548.30748.2e
Subject(s) - olaparib , medicine , oncology , durvalumab , ovarian cancer , brca mutation , parp inhibitor , cancer , bevacizumab , germline , gynecology , nivolumab , chemotherapy , immunotherapy , biology , biochemistry , polymerase , gene , poly adp ribose polymerase